Uwe Wollina
Dresden University of Technology
1086 Papers
4.3K Citations
Uwe Wollina is an academic researcher from Dresden University of Technology. The author has contributed to research in topics: Medicine & Psoriasis. The author has an hindex of 48, co-authored 1033 publications. Previous affiliations of Uwe Wollina include University of Jena & Medical University Plovdiv.
Chat about Author
Papers
New Trends in Cutaneous Melanoma Surgery.
Jacopo Scala,Aleksandra Vojvodic,Petar Vojvodic,Tatjana Vlaskovic-Jovicevic,Zorica Peric-Hajzler,Dusica Matovic,Sanja Dimitrijevic,Jovana Vojvodic,Goran Sijan,Nenad Stepic,Uwe Wollina,Michael Tirant,Van Thuong Nguyen,Massimo Fioranelli,Torello Lotti +14 more
TL;DR: This review aims to present data for the optimal surgical management of patients with malignant melanoma with the introduction of new systemic therapies, like BRAF inhibitors, MEK inhibitors and antibodies anti-PD-1.
5
Major Developments in Wound Care: A Critical Appraisal:
TL;DR: A number of positive effects of moist wound healing have been described, which are of potential interest in chronic wounds, and there is such an amount of moisture (discharge) that it threatens the epidermal integrity of the surrounding skin.
5
Occlusive treatment enhances efficacy of tacrolimus 0.1% in a pediatric patient with severe alopecia areata: Case report and literature review.
TL;DR: A 6‐year‐old patient with Down syndrome who was treated with topical tacrolimus 0.1% ointment under occlusion overnight with remarkable clinical improvement within 4 months is presented.
5
Kerion Celsi due to Microsporum canis infection
TL;DR: In this paper, an 11-year-old Jungen mit Kerion Celsi, unter der haufigen Fehldiagnose einer bakteriellen Infektion antibiotisch therapiert wurde, nach mykologischer Diagnostik konnte eine Infaktion mit Microsporum canis gesichert werden.
5
•Journal Article
Failure of vismodegib in advanced Basal cell carcinoma.
G. Hansel,Georgi Tchernev,Anastasiya Atanasova Chokoeva,Torello Lotti,Jaqueline Schönlebe,Uwe Wollina +5 more
TL;DR: A 38-year-old female patient with a large multicentric BCC of temple with primary chemoresistance of the tumor is reported, and possible mechanism and other limitations of vismodegib in BCC are discussed.
5